Genomics and Proteomics of Nucleoside Transporters

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|3|4|281-287

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.3, Iss.4, 2005-01, pp. : 281-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Technology: methodologies in genomics and proteomics

By Jon T.   John M.   Chris M.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney

By Mangravite L.M.   Badagnani I.   Giacomini K.M.  

European Journal of Pharmacology, Vol. 479, Iss. 1, 2003-10 ,pp. : 269-281

Elsevier

Access to resources Recommend Favorite

Companies Applying Genomics and Proteomics to Cancer

By  

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 1, 2003-01 ,pp. : 60-63

Adis International

Access to resources Recommend Favorite

Genomics, proteomics: what’s next?

By Willett James D  

Pharmacogenomics, Vol. 3, Iss. 6, 2002-11 ,pp. : 727-728

Future Medicine

Access to resources Recommend Favorite

Managing core resources for genomics and proteomics

By Apweiler Rolf   Martin Maria Jesus   O’Donovan Claire   Pruess Manuela  

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 343-350

Future Medicine

Access to resources Recommend Favorite